肥胖是否保护脓毒症患者免于死亡?55,038例成人患者的回顾性队列研究
该回顾性队列研究纳入美国139家医院2009至2015年55,038例符合Sepsis-3标准的成人脓毒症患者,按体重指数分为六类,用多因素logistic回归(广义估计方程)分析其与短期死亡(院内死亡或出院转临终关怀)的关系。粗死亡率随体重指数升高而下降:低体重31%、正常体重24%、超重19%、肥胖I级16%、肥胖II级16%、肥胖III级14%。校正后,与正常体重相比,低体重死亡风险增高(OR 1.62,95%CI 1.50-1.74),超重及各级肥胖死亡风险降低(OR 0.73至0.61)。敏感性分析结果一致。作者认为,理解肥胖改善脓毒症生存的机制有助于预后判断和治疗策略。
要点
- 校正混杂后,与正常体重相比,低体重脓毒症患者短期死亡风险增高:OR 1.62(95%CI 1.50-1.74)。
- 超重及肥胖I-III级患者短期死亡风险均低于正常体重:OR分别为0.73、0.61、0.61、0.65(95%CI均不跨1)。
- 粗死亡率随体重指数升高而下降:低体重31%、正常24%、超重19%、肥胖I级16%、肥胖II级16%、肥胖III级14%。
- 年龄、性别、Elixhauser合并症指数、SOFA四分位、菌血症脓毒症及ICU亚组的敏感性分析结果一致。
适用人群与场景
- 美国139家医院2009至2015年收治的符合Sepsis-3标准的成人脓毒症住院患者,共55,038例,均有可评估的体重指数测量。
诊断标准与关键阈值
- 脓毒症定义采用Sepsis-3标准。
- 体重指数分类:低体重<18.5 kg/m²,正常体重18.5-24.9 kg/m²,超重25.0-29.9 kg/m²,肥胖I级30.0-34.9 kg/m²,肥胖II级35.0-39.9 kg/m²,肥胖III级≥40 kg/m²。
研究设计与关键结果
- 研究类型为回顾性队列分析,数据来自大型临床数据仓库,覆盖美国139家医院;2009至2015年纳入55,038例成人脓毒症患者,体重指数分布为低体重6%、正常体重33%、超重28%、肥胖33%。
- 主要终点为短期死亡(院内死亡或出院转临终关怀),采用多因素logistic回归加广义估计方程校正患者、感染及医院层面因素。
- 粗死亡率:低体重31%、正常体重24%、超重19%、肥胖I级16%、肥胖II级16%、肥胖III级14%。
- 与正常体重相比,校正后死亡OR(95%CI):低体重1.62(1.50-1.74)、超重0.73(0.70-0.77)、肥胖I级0.61(0.57-0.66)、肥胖II级0.61(0.55-0.67)、肥胖III级0.65(0.59-0.71)。
- 年龄、性别、Elixhauser合并症指数、SOFA四分位、菌血症脓毒症及ICU入住亚组的敏感性分析结果一致。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,理解肥胖改善脓毒症生存的机制可为预后判断和治疗策略提供信息。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Observational studies suggest obesity is associated with sepsis survival, but these studies are small, fail to adjust for key confounders, measure body mass index at inconsistent time points, and/or use administrative data to define sepsis. To estimate the relationship between body mass index and sepsis mortality using detailed clinical data for case detection and risk adjustment.
DESIGN: Retrospective cohort analysis of a large clinical data repository.
SETTING: One-hundred thirty-nine hospitals in the United States.
PATIENTS: Adult inpatients with sepsis meeting Sepsis-3 criteria.
EXPOSURE: Body mass index in six categories: underweight (body mass index < 18.5 kg/m), normal weight (body mass index = 18.5-24.9 kg/m), overweight (body mass index = 25.0-29.9 kg/m), obese class I (body mass index = 30.0-34.9 kg/m), obese class II (body mass index = 35.0-39.9 kg/m), and obese class III (body mass index ≥ 40 kg/m).
MEASUREMENTS: Multivariate logistic regression with generalized estimating equations to estimate the effect of body mass index category on short-term mortality (in-hospital death or discharge to hospice) adjusting for patient, infection, and hospital-level factors. Sensitivity analyses were conducted in subgroups of age, gender, Elixhauser comorbidity index, Sequential Organ Failure Assessment quartiles, bacteremic sepsis, and ICU admission.
MAIN RESULTS: From 2009 to 2015, we identified 55,038 adults with sepsis and assessable body mass index measurements: 6% underweight, 33% normal weight, 28% overweight, and 33% obese. Crude mortality was inversely proportional to body mass index category: underweight (31%), normal weight (24%), overweight (19%), obese class I (16%), obese class II (16%), and obese class III (14%). Compared with normal weight, the adjusted odds ratio (95% CI) of mortality was 1.62 (1.50-1.74) for underweight, 0.73 (0.70-0.77) for overweight, 0.61 (0.57-0.66) for obese class I, 0.61 (0.55-0.67) for obese class II, and 0.65 (0.59-0.71) for obese class III. Results were consistent in sensitivity analyses.
CONCLUSIONS: In adults with clinically defined sepsis, we demonstrate lower short-term mortality in patients with higher body mass indices compared with those with normal body mass indices (both unadjusted and adjusted analyses) and higher short-term mortality in those with low body mass indices. Understanding how obesity improves survival in sepsis would inform prognostic and therapeutic strategies.
参考来源
- Pepper DJ, Demirkale CY, Sun J, et al. Does Obesity Protect Against Death in Sepsis? A Retrospective Cohort Study of 55,038 Adult Patients. Crit Care Med. 2019. PMID: 30789403. doi:10.1097/CCM.0000000000003692
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。